首页> 外文期刊>Journal of biomedical materials research, Part A >Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L -lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo
【24h】

Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L -lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo

机译:填充纤维蛋白凝胶,间充质干细胞和聚(环氧乙烷)-b-聚(L-赖氨酸)/TGF-β1质粒DNA复合物的聚丙交酯-乙交酯共聚物支架的体内软骨修复

获取原文
获取原文并翻译 | 示例
       

摘要

A poly (lactide-co-glycolide) (PLGA) scaffold filled with fibrin gel, mesenchymal stem cells (MSCs) and poly(ethylene oxide)-b-poly (L-lysine) (PEO-b-PLL)/pDNA-TGF-β1 complexes was fabricated and applied in vivo for synchronized regeneration of cartilage and subchondral bone. The PEO-b-PLL/pDNA-TGF-β1 complexes could transfect MSCs in vitro to produce TGF-β1 in situ and up regulate the expression of chondrogenesis-related genes in the construct. The expression of heterogeneous TGF-β1 in vivo declined along with the prolongation of implantation time, and lasted for 3 and 6 weeks in the mRNA and protein levels, respectively. The constructs (Experimental group) of PLGA/fibrin gel/MSCs/(PEO-b-PLL/pDNA-TGF-β1 complexes) were implanted into the osteochondral defects of rabbits to restore the functional cartilages, with gene-absent constructs as the Control. After 12 weeks, the Experimental group regenerated the neo-cartilage and subchondral bone with abundant deposition of glycosaminoglycans (GAGs) and type II collagen. The regenerated tissues had good integration with the host tissues too. By contrast, the defects were only partially repaired by the Control constructs. qRT-PCR results demonstrated that expression of the chondrogenesis-marker genes in the Experimental group was significantly higher than that of the Control group, and was very close to that of the normal cartilage tissue.
机译:填充有血纤蛋白凝胶,间充质干细胞(MSC)和聚(环氧乙烷)-b-聚(L-赖氨酸)(PEO-b-PLL)/ pDNA-TGF的聚(丙交酯-乙交酯)(PLGA)支架制备了β1复合物,并在体内用于软骨和软骨下骨的同步再生。 PEO-b-PLL /pDNA-TGF-β1复合物可以在体外转染MSC,以原位产生TGF-β1,并上调软骨生成相关基因在构建物中的表达。 TGF-β1在体内的表达随植入时间的延长而下降,并在mRNA和蛋白质水平分别持续3和6周。将PLGA /纤维蛋白凝胶/ MSCs /(PEO-b-PLL /pDNA-TGF-β1复合物)的构建体(实验组)植入兔的骨软骨缺损中以恢复功能软骨,以基因缺失的构建体作为对照。 。 12周后,实验组再生了新的软骨和软骨下骨,其中富含氨基糖聚糖(GAG)和II型胶原。再生组织也与宿主组织具有良好的整合。相反,缺陷仅由对照构建体部分修复。 qRT-PCR结果表明,实验组中软骨形成标记基因的表达明显高于对照组,并且与正常软骨组织的表达非常接近。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号